Search by Drug Name or NDC

    NDC 67877-0247-38 Quetiapine Fumarate 300 mg/1 Details

    Quetiapine Fumarate 300 mg/1

    Quetiapine Fumarate is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Ascend Laboratories, LLC. The primary component is QUETIAPINE FUMARATE.

    Product Information

    NDC 67877-0247
    Product ID 67877-247_3c142a5f-4b76-426e-a59a-00ceaa73be3b
    Associated GPIs 59153070100340
    GCN Sequence Number 047198
    GCN Sequence Number Description quetiapine fumarate TABLET 300 MG ORAL
    HIC3 H7T
    HIC3 Description ANTIPSYCHOTIC,ATYPICAL,DOPAMINE,SEROTONIN ANTAGNST
    GCN 67665
    HICL Sequence Number 014015
    HICL Sequence Number Description QUETIAPINE FUMARATE
    Brand/Generic Generic
    Proprietary Name Quetiapine Fumarate
    Proprietary Name Suffix n/a
    Non-Proprietary Name Quetiapine Fumarate
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 300
    Active Ingredient Units mg/1
    Substance Name QUETIAPINE FUMARATE
    Labeler Name Ascend Laboratories, LLC
    Pharmaceutical Class Atypical Antipsychotic [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA201504
    Listing Certified Through 2024-12-31

    Package

    NDC 67877-0247-38 (67877024738)

    NDC Package Code 67877-247-38
    Billing NDC 67877024738
    Package 10 BLISTER PACK in 1 CARTON (67877-247-38) / 10 TABLET in 1 BLISTER PACK
    Marketing Start Date 2013-03-01
    NDC Exclude Flag N
    Pricing Information N/A